Mackenzie Financial’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Buy
66,807
+41,319
+162% +$942K ﹤0.01% 1140
2026
Q2
$656K Buy
+25,488
New +$590K ﹤0.01% 1263
2025
Q3
– Sell
-44,336
Closed -$1.02M – 1814
2025
Q2
$1.02M Sell
44,336
-1,783
-4% -$41.3K ﹤0.01% 1007
2025
Q1
$1.04M Sell
46,119
-26,272
-36% -$610K ﹤0.01% 968
2024
Q4
$1.42M Buy
72,391
+33,728
+87% +$668K ﹤0.01% 860
2024
Q3
$704K Buy
+38,663
New +$738K ﹤0.01% 945
2022
Q4
– Sell
-27,135
Closed -$924K – 1553
2022
Q3
$924K Buy
+27,135
New +$1M ﹤0.01% 831

Other funds holding PRVA

Mackenzie Financial's PRVA Position: Q3 2026 in Review

Mackenzie Financial increased its Privia Health (PRVA) stake by 162% in Q3 2026, buying an estimated $942K and bringing the position to 66,807 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Mackenzie Financial first reported a position in PRVA in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.42M in Q4 2024. 87 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Mackenzie Financial held 66,807 shares of Privia Health worth $1.32M as of Q3 2026.
  • Mackenzie Financial bought 41,319 Privia Health shares in Q3 2026, an estimated $942K.
  • Privia Health made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1140 holding.
  • Mackenzie Financial first reported a position in Privia Health in Q3 2022 and has held it in 7 quarters since.
  • Mackenzie Financial's Privia Health position peaked at $1.42M in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.